- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological Treatment of Alzheimer Disease
Authors
Keywords
-
Journal
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
Volume 56, Issue 10, Pages 579-588
Publisher
SAGE Publications
Online
2017-01-11
DOI
10.1177/070674371105601003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell Signaling Pathways and Iron Chelation in the Neurorestorative Activity of Green Tea Polyphenols: Special Reference to Epigallocatechin Gallate (EGCG)
- (2017) Silvia A. Mandel et al. JOURNAL OF ALZHEIMERS DISEASE
- The Quest for Small Molecules as Amyloid Inhibiting Therapies for Alzheimer's Disease
- (2017) Hozefa Amijee et al. JOURNAL OF ALZHEIMERS DISEASE
- The Neurodegenerative Mitochondriopathies
- (2017) Russell H. Swerdlow JOURNAL OF ALZHEIMERS DISEASE
- PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses
- (2017) Noel G. Faux et al. JOURNAL OF ALZHEIMERS DISEASE
- Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline
- (2013) Parminder Raina et al. ANNALS OF INTERNAL MEDICINE
- Current Pharmacologic Treatment of Dementia: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians
- (2013) Amir Qaseem ANNALS OF INTERNAL MEDICINE
- Virus-like particle based vaccines for Alzheimer disease
- (2011) Bryce Chackerian Human vaccines & immunotherapeutics
- Update on the Pharmacological Treatment of Alzheimers Disease
- (2010) Fadi Massoud et al. Current Neuropharmacology
- Intravenous Immunoglobulins as a Treatment for Alzheimerʼs Disease
- (2010) Richard Dodel et al. DRUGS
- Switching cholinesterase inhibitors in older adults with dementia
- (2010) Fadi Massoud et al. INTERNATIONAL PSYCHOGERIATRICS
- Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis
- (2010) S. W. Pimplikar et al. JOURNAL OF NEUROSCIENCE
- Why are drug trials in Alzheimer's disease failing?
- (2010) The Lancet LANCET
- Alzheimer's disease: clinical trials and drug development
- (2010) Francesca Mangialasche et al. LANCET NEUROLOGY
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exebryl-1: A novel small molecule currently in human clinical trials as a disease-modifying drug for the treatment of Alzheimer's disease
- (2009) Alan D. Snow et al. Alzheimers & Dementia
- Beta-secretase as target for amyloid-reduction therapy
- (2009) Jordan J.N. Tang Alzheimers & Dementia
- Effects of rosiglitazone as monotherapy in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease
- (2009) Michael Gold et al. Alzheimers & Dementia
- Drug development for Alzheimer's disease: Where are we now and where are we headed?
- (2009) Marwan N. Sabbagh American Journal Geriatric Pharmacotherapy
- Modulation of fusiform cortex activity by cholinesterase inhibition predicts effects on subsequent memory
- (2009) P. Bentley et al. BRAIN
- Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
- (2009) Bruno Vellas et al. Current Alzheimer Research
- Memantine: a comprehensive review of safety and efficacy
- (2009) Harish Kavirajan Expert Opinion On Drug Safety
- Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease
- (2009) David B Henley et al. EXPERT OPINION ON PHARMACOTHERAPY
- Secretase inhibitors and modulators for Alzheimer’s disease treatment
- (2009) Taisuke Tomita Expert Review of Neurotherapeutics
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial
- (2009) Robert C. Green JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Can Lithium or Valproate Untie Tangles in Alzheimer's Disease?
- (2009) Pierre N. Tariot et al. JOURNAL OF CLINICAL PSYCHIATRY
- The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal
- (2009) John Hardy JOURNAL OF NEUROCHEMISTRY
- Effect of tramiprosate in patients with mild-to-moderate alzheimer’s disease: Exploratory analyses of the MRI sub-group of the alphase study
- (2009) S. Gauthier et al. Journal of Nutrition Health & Aging
- Treatment of vascular risk factors is associated with slower decline in Alzheimer disease
- (2009) Y. Deschaintre et al. NEUROLOGY
- Cool with Plaques and Tangles
- (2009) Douglas C. Ewbank et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age, Neuropathology, and Dementia
- (2009) George M. Savva et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of infarcts on dementia in the Baltimore longitudinal study of aging
- (2008) Juan C. Troncoso et al. ANNALS OF NEUROLOGY
- Neurofibrillary degeneration in Alzheimerʼs disease: from molecular mechanisms to identification of drug targets
- (2008) Jin-Jing Pei et al. CURRENT OPINION IN PSYCHIATRY
- Reassessing the amyloid cascade hypothesis of Alzheimer's disease
- (2008) Sanjay W. Pimplikar INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau
- (2008) K. N. Green et al. JOURNAL OF NEUROSCIENCE
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
- (2008) Rachelle S Doody et al. LANCET
- Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
- (2008) Lars Lannfelt et al. LANCET NEUROLOGY
- Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial
- (2008) Gordon K Wilcock et al. LANCET NEUROLOGY
- Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
- (2008) Ruth Peters et al. LANCET NEUROLOGY
- 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
- (2008) Norman R. Relkin et al. NEUROBIOLOGY OF AGING
- Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ
- (2008) Paul A. Adlard et al. NEURON
- PPARγ agonists as therapeutics for the treatment of Alzheimer’s disease
- (2008) Gary Landreth et al. Neurotherapeutics
- Treatment of Hypertension in Patients 80 Years of Age or Older
- (2008) Nigel S. Beckett et al. NEW ENGLAND JOURNAL OF MEDICINE
- Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease
- (2008) P. Hemachandra Reddy et al. TRENDS IN MOLECULAR MEDICINE
- Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways
- (2007) Hani Atamna et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started